Clinical Trial Update: Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 safety, tolerability, pharmacokinetic and pharmacodynamic study of PF-06291874 as oral monotherapy in adults with type 2 diabetes mellitus. The trial ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PF-06291874

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type II | Phase 2 | Status: COMPLETED | Results posted: 2016-06-15